Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 10897  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 :: Next article
 :: Previous article 
 :: Table of Contents
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::  Article in PDF (83 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article

 Article Access Statistics
    PDF Downloaded163    
    Comments [Add]    
    Cited by others 2    

Recommend this journal


Year : 2006  |  Volume : 52  |  Issue : 2  |  Page : 100-101

Prophylaxis of postoperative nausea and vomiting: Gabapentin a new anti-emetic approach?

Department of Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen Bremserstraße 79, D-67063 Ludwigshafen, Germany

Correspondence Address:
S N Piper
Department of Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen Bremserstraße 79, D-67063 Ludwigshafen
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

How to cite this article:
Piper S N. Prophylaxis of postoperative nausea and vomiting: Gabapentin a new anti-emetic approach?. J Postgrad Med 2006;52:100-1

How to cite this URL:
Piper S N. Prophylaxis of postoperative nausea and vomiting: Gabapentin a new anti-emetic approach?. J Postgrad Med [serial online] 2006 [cited 2023 Jun 10];52:100-1. Available from:

Every third patient undergoing general anaesthesia suffers from postoperative nausea and vomiting (PONV).[1] Although more than 1000 investigations on prevention or treatment of PONV have been published, the incidence of PONV has been unchanged over the past two decades.[2] The ideal drug has not yet been found and no gold-standard exists.[3] The occurence of PONV depends on numerous factors including female gender, non-smoking status, a history of previous PONV and/or motion sickness, the duration of anaesthesia and the postoperative use of opioids.[1] Although less important, PONV may be influenced by the type of surgery as well, especially strabismus correction and laparoscopic surgery have been described as risk-factors of PONV.[4],[5] Therefore, in patients with a high risk profile of PONV, including the above mentioned factors attributing to a higher incidence of PONV (e.g. non-smoking females of child-bearing age with a previous episode of nausea or/and vomiting or kinetosis in the patient's history), combinations of antiemetic interventions have been recommended.[1],[2] In a large study, Christian Apfel and colleagues showed that various anti-emetic strategies are associated with a very similar and constant relative reduction rate of about 25-30%.[1] All evaluated anti-emetic approaches (dexamethasone, droperidol, total intravenous anaesthesia and ondansetron) work independently, so consequently their combined benefit can be derived directly from the single effects.[1]

The present issue of the Journal contains an article[6] reporting the results of a trial evaluating the efficacy of the antiepileptic drug gabapentin for prevention of PONV. The authors were able to demonstrate, that gabapentin has antiemetic properties of clinical relevance. However, more clinical trials are needed to evaluate dose-finding and safety-studies, as well as comparisons to established antiemetic strategies and a potential combined benefit of gabapentin and other established anti-emetic interventions. The present study raises hope that gabapentin might be an effective and safe new approach in the clinical antiemetic portfolio that may be used as a component of a multimode solution using various antiemetic interventions for high-risk patients. However, avoiding PONV while minimizing the chances of producing unwanted side-effects still remains a challenge.

  References Top

1.Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, et al . A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441-51.  Back to cited text no. 1    
2.White PF. Prevention of postoperative nausea and vomiting - a multimodal solution to a persistent problem. N Engl J Med 2004;350:2511-2.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Tramer MR. A rational approach to the control of postoperative nausea and vomiting:evidence from systemic reviews. I. Efficacy and harm of antiemetic interventions and methodological issues. Acta Anaesthesiol Scand 2001;45:4-13.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Piper SN, Suttner SW, R φhm KD, Maleck WH, Larbig E, Boldt J. Dolasetron, but not metoclopramide prevents nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Can J Anaesth 2002;49:1021-8.  Back to cited text no. 4    
5.Apfel CC, Greim CA, Haubitz I, Grundt D, Goepfert C, Sefrin P, et al . The discriminating power of a risk score for postoperative vomiting in adults undergoing various types of surgery. Acta Anaesthesiol Scand 1998;42:502-9.  Back to cited text no. 5    
6.Pandey CK, Priye S, Ambesh SP, Singh S, Singh U, Singh PK. Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomized, double-blind, placebo-controlled study. J Postgard Med 2006;52:95-9.  Back to cited text no. 6    

This article has been cited by
1 Postoperative analgosedation with S(+)-ketamine decreases the incidences of postanesthetic shivering and nausea and vomiting after cardiac surgery
Piper, S.N., Beschmann, R., Mengistu, A., Maleck, W.H., Boldt, J., Röhm, K.D.
Medical Science Monitor. 2008; 14(12): P159-P165
2 Incentives to encourage peer review
Choi BCK


Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow